Biostem Technologies Financials
| BSEM Stock | USD 14.44 0.98 6.36% |
With this module, you can analyze Biostem financials for your investing period. You should be able to track the changes in Biostem Technologies individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Biostem |
Understanding current and past Biostem Technologies Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Biostem Technologies' financial statements are interrelated, with each one affecting the others. For example, an increase in Biostem Technologies' assets may result in an increase in income on the income statement.
The data published in Biostem Technologies' official financial statements typically reflect Biostem Technologies' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Biostem Technologies' quantitative information. For example, before you start analyzing numbers published by Biostem accountants, it's essential to understand Biostem Technologies' liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
Biostem Technologies Stock Summary
Biostem Technologies competes with Genfit, HCW Biologics, Protara Therapeutics, Genelux Common, and Dyadic International. BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. BioStem Technologies, Inc. was incorporated in 2006 and is based in Pompano Beach, Florida. Biostem Technologies is traded on OTC Exchange in the United States.| Instrument | USA OTC Stock View All |
| Exchange | OTCQB Exchange |
| ISIN | US0906842002 |
| Business Address | 2836 Center Port |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.biostemtechnologies.com |
| Phone | 954 380 8342 |
| Currency | USD - US Dollar |
Biostem Technologies Key Financial Ratios
There are many critical financial ratios that Biostem Technologies' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Biostem Technologies reports annually and quarterly.Biostem Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biostem Technologies's current stock value. Our valuation model uses many indicators to compare Biostem Technologies value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biostem Technologies competition to find correlations between indicators driving Biostem Technologies's intrinsic value. More Info.Biostem Technologies is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biostem Technologies' earnings, one of the primary drivers of an investment's value.Biostem Technologies Systematic Risk
Biostem Technologies' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Biostem Technologies volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Biostem Technologies correlated with the market. If Beta is less than 0 Biostem Technologies generally moves in the opposite direction as compared to the market. If Biostem Technologies Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Biostem Technologies is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Biostem Technologies is generally in the same direction as the market. If Beta > 1 Biostem Technologies moves generally in the same direction as, but more than the movement of the benchmark.
Biostem Technologies December 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Biostem Technologies help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Biostem Technologies. We use our internally-developed statistical techniques to arrive at the intrinsic value of Biostem Technologies based on widely used predictive technical indicators. In general, we focus on analyzing Biostem OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Biostem Technologies's daily price indicators and compare them against related drivers.
| Downside Deviation | 7.45 | |||
| Information Ratio | 0.1083 | |||
| Maximum Drawdown | 43.73 | |||
| Value At Risk | (6.97) | |||
| Potential Upside | 12.51 |
Other Information on Investing in Biostem OTC Stock
Biostem Technologies financial ratios help investors to determine whether Biostem OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biostem with respect to the benefits of owning Biostem Technologies security.